Rite Aid Corp (RAD)
$13.78
1.36 (8.98%)
RAD Stock Quote Delayed 15 Minutes
Previous Close
$15.10
Market Cap
14.70B
PE Ratio
-40.53
EPS
-0.34
Volume (Avg. Vol.)
3.16M
Day's Range
13.75 - 15.38
52-Week Range
0.43 - 23.88
Dividend & Yield
N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
Collect on Rite Aid’s Short-Term Bullishness
My regular readers know I never want to buck the tape, or go against the action in the market, which is why I am recommending a bullish call option on Rite Aid Corporation (NYSE:RAD).
Right Now the Turnaround Hopes for RAD Stock Look Overstated
RAD stock is trading as if the Rite Aid turnaround is a certainty, but it's anything but that, and that makes the stock quite risky.
5 Top Stock Trades for Friday: NVDA, ROKU, MSFT, RAD, CTL
Roku and Nvidia earnings previews, plus Centurylink, Rite Aid and Microsoft were our top stock trades for Friday.
High-Tech Disruptors Are Coming to Sink Old-School Rite Aid
RAD stock jumped higher off a strong Q4 earnings beat but without a viable recovery narrative. This is where the story ends.
Rite Aid Stock: Risk Lovers, Speculators Inquire Within
There's an old investment saying that goes something like (forgive my paraphrasing) “credit leads equity.” What that means is that a company's corporate debt can be a tell about future price action in the stock. Rite Aid recently exchanged $600 million in notes coming due in 2023 for notes maturing in 2025. While that move will help with interest expense, at least one ratings agency doesn't see a reason to upgrade the company's flimsy credit rating.
It’s Super Speculative, but RAD Stock May Actually Be a Buy
Rite Aid is still a risky play, but the technicals finally look attractive and the fundamentals are improving for RAD stock.
Rite Aid Stock Could Break $14 Resistance, Or $11 Support
Rite Aid shares have been seized with volatility, making RAD stock a toss-up play for bears and bulls alike.
After Last Month’s Epic Rally, Rite Aid Stock Could Go Lower
Outside of another short squeeze, it's tough to see RAD stock going higher long-term. Even after the rally, shares remain a sell.
Investors Will See What They Want in RAD Stock
RAD stock appears like an interesting bet considering its present market discount. However, speculators should be aware that the company’s financial health leaves much to be desired.
To Stay at $20, Rite Aid’s Got to Do More
Although Rite Aid stock has come a long way, the reality is that the fundamental picture is incredibly messy. Management must reveal more substance before investors have any confidence in the beleaguered company.
Rite Aid Stock Is a Bottom Fisher’s Paradise at Its Current Price
Bargains in the health-care sector like RAD stock don't come along all that often. It's time to go against the grain and pick up some shares.
Don’t Be Fooled by the Big Spike of Rite Aid Stock
RAD stock nearly tripled in the last month of 2019, but Rite Aid stock subsequently fell and looks poised for more declines.
Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020
With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.
4 Top Stock Trades for Friday: TSLA, RAD, GIS, MED
General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.
Rite Aid Earnings: RAD Stock Rockets 43% Higher on Better-Than-Expected Q3
Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
